Carrier-mediated transport to enhance drug delivery to brain

International Congress Series

Volumn 1277, Issue , 2005, Pages 63-74

  Smith, Quentin R ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Amino acid; Blood brain barrier; Carrier mediated transport; Gabapentin; l DOPA; Melphalan

Indexed keywords

EID: 33645319877     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.ics.2005.02.012     Document Type: Article

References (25)

1. Neuwelt E.A. Mechanisms of disease: the blood-brain barrier. Neurosurgery 54 (2004) 131-140
2. Pardridge W.M. Brain drug targeting: the future of brain drug development (2001), Cambridge University Press, Cambridge
3. Bartus R. Drug delivery to the brain: the problem lurking behind the problem?. Neurobiol. Aging 10 (1989) 621-629
4. Habgood M.D., Begley D.J., and Abbott N.J. Determinants of passive drug entry into the central nervous system. Cell. Mol. Neurobiol. 20 (2000) 231-253
5. Clark D.E. In silico prediction of blood-brain barrier permeation. Drug Discov. Today 8 (2003) 927-933
6. Sun H., et al. Drug efflux transporters in the CNS. Adv. Drug Deliv. Rev. 55 (2003) 83-105
7. Graff C.L., and Pollack G.M. Drug transport at the blood-brain barrier and the choroid plexus. Curr. Drug Metab. 5 (2004) 95-108
8. Takasawa K., et al. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive system. J. Pharmacol. Exp. Ther. 281 (1997) 369-375
9. Jezequel S.G. Central nervous system penetration of drugs: importance of physiochemical properties. Prog. Drug Metab. 13 (1992) 132-187
10. Greig N.H., et al. Physiochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration. Cancer Chemother. Pharmacol. 25 (1990) 311-319
11. Greig N.H., et al. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Cancer Chemother. Pharmacol. 25 (1990) 320-325
12. Smith Q.R. Drug delivery to brain and the role of carrier-mediated transport. Adv. Exp. Med. Biol. 331 (1992) 83-93
13. Begley D.J., and Brightman M.W. Structural and functional aspects of the blood-brain barrier. Prog. Drug Res. 61 (2003) 41-78
14. Smith Q.R. Transport of glutamate and other amino acids at the blood-brain barrier. J. Nutr. 130 (2000) 1016-1022
15. Kanai Y., et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273 (1998) 23629-23632
16. Smith Q.R., et al. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 49 (1987) 1651-1658
17. Takada Y., et al. Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier. Cancer Res. 52 (1992) 2191-2196
18. Nawashiro H., et al. The role of CD98 in astrocytic neoplasms. Hum. Cell 15 (2002) 25-31
19. Takada Y., et al. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother. Pharmacol. 29 (1991) 89-94
20. Greig N.H., et al. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res. 47 (1987) 1571-1576
21. Fekete I., et al. Rate of buthionine sulfoximine entry into brain and xenotransplanted human gliomas. Cancer Res. 50 (1990) 1251
22. Groothuis D.R., et al. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma. Cancer Res. 52 (1992) 5590
23. Greig N.H., Sweeney D.J., and Rapoport S.I. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Cancer Chemother. Pharmacol. 21 (1988) 1
24. Haines D.R., et al. Selective cytotoxicity of a system l specific amino acid nitrogen mustard. J. Med. Chem. 30 (1987) 542
25. Allen D.D., and Smith Q.R. Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J. Neurochem. 76 (2001) 1032-1041